The statements within this website are for infomational purposes only: Disclaimer

Basilea Pharmaceutica AG

Company Information
Address Grenzacherstrasse 487
Country Switzerland
Phone +41 61 606 1233
Business Sector Pharmaceuticals & Biotechnology
Brief Overview Basilea Pharmaceutica AG founded in 2000 is an independent biopharmaceutical company headquartered in Basel, Switzerland that is engaged in the discovery and development of medicines for the treatment of unmet medical needs. The company's fully integrated research and development operations are currently focused on new anti-bacterial agents, anti-fungal agents and dermatology drugs.
Chief Executive Officer Anthony Man
Auditors PricewaterhouseCoopers
No. of Employees 175
Going Public
Exchange Swiss Exchange
IPO Date March 25, 2004
Share Identification Number 1143244
Symbol BSLN
Subscription Period 03,11,2004 to 03,24,2004
Lead Underwriter Credit Suisse First Boston
Underwriters Morgan Stanley
Total No. of Shares in Issue after Going Public 7,380,141
No. of Offered Shares 2,100,000
Greenshoe 315,000
Total No. of Issued Share (inkl. Greenshoe) 32.7%
Firm Offer Price CHF 98
Expected Market Cap. CHF 723 Mio.
First Day Close CHF 101
Numbers (in 1000 CHF)
Last Fiscal Year End Date Prior to Going Public December 31, 2003
Turnover 2003
Equity on Last Balance Date 0
Total Assets 0
Ratio of Equity to Total Capital on Balance Date %